Windtree Therapeutics (WINT) Expected to Announce Quarterly Earnings on Tuesday

Windtree Therapeutics (NASDAQ:WINT) is anticipated to post its quarterly earnings results before the market opens on Tuesday, April 15th. Analysts expect the company to announce earnings of ($23.32) per share for the quarter.

Windtree Therapeutics Stock Performance

Shares of NASDAQ WINT opened at $1.20 on Tuesday. The stock’s 50-day simple moving average is $3.72 and its 200-day simple moving average is $24.80. The firm has a market capitalization of $898,800.00, a PE ratio of -0.07 and a beta of 0.91. Windtree Therapeutics has a fifty-two week low of $1.10 and a fifty-two week high of $737.44.

About Windtree Therapeutics

Windtree Therapeutics, Inc, a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. The company’s lead product candidate is istaroxime, which is in Phase 2b clinical trial for the treatment of acute decompensated heart failure, as well as for the treatment of early cardiogenic shock.